美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA209312"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
50090-3556-4 50090-3556 HUMAN PRESCRIPTION DRUG Methocarbamol Methocarbamol Tablets TABLET, COATED ORAL 20180702 N/A ANDA ANDA209312 A-S Medication Solutions METHOCARBAMOL 750 mg/1 60 TABLET, COATED in 1 BOTTLE, PLASTIC (50090-3556-4)
50090-3556-6 50090-3556 HUMAN PRESCRIPTION DRUG Methocarbamol Methocarbamol Tablets TABLET, COATED ORAL 20180702 N/A ANDA ANDA209312 A-S Medication Solutions METHOCARBAMOL 750 mg/1 100 TABLET, COATED in 1 BOTTLE, PLASTIC (50090-3556-6)
50090-3556-7 50090-3556 HUMAN PRESCRIPTION DRUG Methocarbamol Methocarbamol Tablets TABLET, COATED ORAL 20180702 N/A ANDA ANDA209312 A-S Medication Solutions METHOCARBAMOL 750 mg/1 12 TABLET, COATED in 1 BOTTLE, PLASTIC (50090-3556-7)
70010-754-01 70010-754 HUMAN PRESCRIPTION DRUG Methocarbamol Methocarbamol Tablets TABLET, COATED ORAL 20200201 N/A ANDA ANDA209312 Granules Pharmaceuticals Inc. METHOCARBAMOL 500 mg/1 100 TABLET, COATED in 1 BOTTLE (70010-754-01)
70010-754-05 70010-754 HUMAN PRESCRIPTION DRUG Methocarbamol Methocarbamol Tablets TABLET, COATED ORAL 20200201 N/A ANDA ANDA209312 Granules Pharmaceuticals Inc. METHOCARBAMOL 500 mg/1 500 TABLET, COATED in 1 BOTTLE (70010-754-05)
35573-413-02 35573-413 HUMAN PRESCRIPTION DRUG Methocarbamol Methocarbamol TABLET, COATED ORAL 20190930 N/A ANDA ANDA209312 Burel Pharmaceuticals, Inc. METHOCARBAMOL 500 mg/1 100 TABLET, COATED in 1 BOTTLE (35573-413-02)
35573-413-04 35573-413 HUMAN PRESCRIPTION DRUG Methocarbamol Methocarbamol TABLET, COATED ORAL 20190930 N/A ANDA ANDA209312 Burel Pharmaceuticals, Inc. METHOCARBAMOL 500 mg/1 500 TABLET, COATED in 1 BOTTLE (35573-413-04)
35573-414-02 35573-414 HUMAN PRESCRIPTION DRUG Methocarbamol Methocarbamol TABLET, COATED ORAL 20190930 N/A ANDA ANDA209312 Burel Pharmaceuticals, Inc. METHOCARBAMOL 750 mg/1 100 TABLET, COATED in 1 BOTTLE (35573-414-02)
35573-414-04 35573-414 HUMAN PRESCRIPTION DRUG Methocarbamol Methocarbamol TABLET, COATED ORAL 20190930 N/A ANDA ANDA209312 Burel Pharmaceuticals, Inc. METHOCARBAMOL 750 mg/1 500 TABLET, COATED in 1 BOTTLE (35573-414-04)
51655-195-51 51655-195 HUMAN PRESCRIPTION DRUG Methocarbamol Methocarbamol Tablets TABLET, COATED ORAL 20221216 N/A ANDA ANDA209312 Northwind Pharmaceuticals, LLC METHOCARBAMOL 500 mg/1 40 TABLET, COATED in 1 BOTTLE, PLASTIC (51655-195-51)
51655-195-52 51655-195 HUMAN PRESCRIPTION DRUG Methocarbamol Methocarbamol Tablets TABLET, COATED ORAL 20221216 N/A ANDA ANDA209312 Northwind Pharmaceuticals, LLC METHOCARBAMOL 500 mg/1 30 TABLET, COATED in 1 BOTTLE, PLASTIC (51655-195-52)
51655-195-84 51655-195 HUMAN PRESCRIPTION DRUG Methocarbamol Methocarbamol Tablets TABLET, COATED ORAL 20221116 N/A ANDA ANDA209312 Northwind Pharmaceuticals, LLC METHOCARBAMOL 500 mg/1 14 TABLET, COATED in 1 BOTTLE, PLASTIC (51655-195-84)
51655-205-20 51655-205 HUMAN PRESCRIPTION DRUG Methocarbamol Methocarbamol Tablets TABLET, COATED ORAL 20230108 N/A ANDA ANDA209312 Northwind Pharmaceuticals, LLC METHOCARBAMOL 750 mg/1 20 TABLET, COATED in 1 BOTTLE, PLASTIC (51655-205-20)
51655-205-52 51655-205 HUMAN PRESCRIPTION DRUG Methocarbamol Methocarbamol Tablets TABLET, COATED ORAL 20230413 N/A ANDA ANDA209312 Northwind Pharmaceuticals, LLC METHOCARBAMOL 750 mg/1 30 TABLET, COATED in 1 BOTTLE, PLASTIC (51655-205-52)
53002-3040-1 53002-3040 HUMAN PRESCRIPTION DRUG Methocarbamol Methocarbamol Tablets TABLET, COATED ORAL 20190101 N/A ANDA ANDA209312 RPK Pharmaceuticals, Inc. METHOCARBAMOL 500 mg/1 10 TABLET, COATED in 1 BOTTLE (53002-3040-1)
53002-3040-2 53002-3040 HUMAN PRESCRIPTION DRUG Methocarbamol Methocarbamol Tablets TABLET, COATED ORAL 20190101 N/A ANDA ANDA209312 RPK Pharmaceuticals, Inc. METHOCARBAMOL 500 mg/1 20 TABLET, COATED in 1 BOTTLE (53002-3040-2)
53002-3040-3 53002-3040 HUMAN PRESCRIPTION DRUG Methocarbamol Methocarbamol Tablets TABLET, COATED ORAL 20190101 N/A ANDA ANDA209312 RPK Pharmaceuticals, Inc. METHOCARBAMOL 500 mg/1 30 TABLET, COATED in 1 BOTTLE (53002-3040-3)
53002-3040-6 53002-3040 HUMAN PRESCRIPTION DRUG Methocarbamol Methocarbamol Tablets TABLET, COATED ORAL 20190101 N/A ANDA ANDA209312 RPK Pharmaceuticals, Inc. METHOCARBAMOL 500 mg/1 60 TABLET, COATED in 1 BOTTLE (53002-3040-6)
53002-3591-2 53002-3591 HUMAN PRESCRIPTION DRUG Methocarbamol Methocarbamol Tablets TABLET, COATED ORAL 20190101 N/A ANDA ANDA209312 RPK Pharmaceuticals, Inc. METHOCARBAMOL 750 mg/1 20 TABLET, COATED in 1 BOTTLE (53002-3591-2)
53002-3591-3 53002-3591 HUMAN PRESCRIPTION DRUG Methocarbamol Methocarbamol Tablets TABLET, COATED ORAL 20190101 N/A ANDA ANDA209312 RPK Pharmaceuticals, Inc. METHOCARBAMOL 750 mg/1 30 TABLET, COATED in 1 BOTTLE (53002-3591-3)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase